These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18018498)

  • 1. Medical costs, utilization rates decline again.
    Manag Care; 2007 Oct; 16(10):55. PubMed ID: 18018498
    [No Abstract]   [Full Text] [Related]  

  • 2. Study shows increases in drug costs may be justified by improvements in outcomes.
    Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
    [No Abstract]   [Full Text] [Related]  

  • 3. By the numbers. The rising costs of prescription drugs.
    Thornton D
    Healthplan; 1999; 40(5):71-2. PubMed ID: 10622972
    [No Abstract]   [Full Text] [Related]  

  • 4. Managed care 2003: the year in review.
    Littman B
    Md Med; 2004; 5(2):8-15. PubMed ID: 15227944
    [No Abstract]   [Full Text] [Related]  

  • 5. Looking back to understand future trends.
    Manag Care; 2008 Oct; 17(10):51. PubMed ID: 18990927
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of the doughnut hole.
    Penna P
    Manag Care Interface; 2007 Sep; 20(9):49-50. PubMed ID: 18161393
    [No Abstract]   [Full Text] [Related]  

  • 8. National drug bill to continue rising by 14%-18%.
    Manag Care; 2003 Jul; 12(7):52. PubMed ID: 12891957
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug costs can be defended.
    Lee AM
    Med Mark Media; 1982 Mar; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug spending keeps rising, but rate of increase slowing.
    Capitation Rates Data; 2001 Aug; 6(8):85-9. PubMed ID: 11526857
    [No Abstract]   [Full Text] [Related]  

  • 11. Health costs decelerate, yet still climb fast.
    Manag Care; 2008 Sep; 17(9):52. PubMed ID: 18839715
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of drug reimportation on managed care pharmacy.
    Penna P
    Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
    [No Abstract]   [Full Text] [Related]  

  • 13. 2009 costs will continue to outpace inflation.
    Manag Care; 2009 Jan; 18(1):50. PubMed ID: 19186673
    [No Abstract]   [Full Text] [Related]  

  • 14. Go beyond demographics to get a handle on pharmacy costs.
    Capitation Manag Rep; 2001 Feb; 8(2):24-5, 17. PubMed ID: 11234360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Medicare Part D doughnut hole: effect on pharmacy utilization.
    Sun SX; Lee KY
    Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed care outlook. Rising deductibles for Part D beneficiaries.
    Manag Care; 2008 Dec; 17(12):49. PubMed ID: 19127768
    [No Abstract]   [Full Text] [Related]  

  • 18. Data watch. The scoop on Rx drug spending.
    Bus Health; 2001 Jun; 19(6):48. PubMed ID: 11434100
    [No Abstract]   [Full Text] [Related]  

  • 19. US health spending up; Medicare expanded.
    Catton M
    CMAJ; 2005 Jun; 172(12):1545. PubMed ID: 15939907
    [No Abstract]   [Full Text] [Related]  

  • 20. National health spending in 2006: a year of change for prescription drugs.
    Catlin A; Cowan C; Hartman M; Heffler S;
    Health Aff (Millwood); 2008; 27(1):14-29. PubMed ID: 18180476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.